Publicaciones (24) Publicaciones en las que ha participado algún/a investigador/a

2018

  1. AdvanceD: kit avanzado hidroferol : la vitamina D, la salud

    Grupo Luzán 5

  2. Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

    The Lancet, Vol. 392, Núm. 10157, pp. 1519-1529

  3. Anastomosis microquirúrgica

    Cirugía oral y maxilofacial: atlas de procedimientos y técnicas quirúrgicas (Editorial Médica Panamericana), pp. 891-896

  4. Complete resolution of dysphagia after sequential Polyflex™ stenting in a case of recurrent anastomotic stenosis in an adult with congenital esophageal atresia

    Revista Española de Enfermedades Digestivas, Vol. 110, Núm. 12, pp. 826-829

  5. Consensus document on osteoporosis in males

    Endocrinologia, Diabetes y Nutricion, Vol. 65, pp. 9-16

  6. Déficit de vitamina D en rehabilitación: recomendaciones en la práctica clínica

    Medical & Marketing Communications

  7. Efficacy and safety of IDegLira versus basal-bolus insulin therapy in patients with type 2 diabetes uncontrolled on metformin and basal insulin: The dual VII randomized clinical trial

    Diabetes Care, Vol. 41, Núm. 5, pp. 1009-1016

  8. El urólogo del futuro y las nuevas tecnologías

    Archivos Espanoles de Urologia, Vol. 71, Núm. 1, pp. 142-149

  9. Endocrine therapy-induced alopecia in patients with breast cancer

    JAMA Dermatology, Vol. 154, Núm. 6, pp. 670-675

  10. Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco-induced lung cancer

    Cancer Medicine, Vol. 7, Núm. 7, pp. 3474-3483

  11. Inflammatory dermatoses, infections, and drug eruptions are the most common skin conditions in hospitalized cancer patients

    Journal of the American Academy of Dermatology, Vol. 78, Núm. 6, pp. 1102-1109

  12. Insulin degludec/liraglutide (IDegLira) was effective across a range of dysglycaemia and body mass index categories in the DUAL V randomized trial

    Diabetes, Obesity and Metabolism, Vol. 20, Núm. 1, pp. 200-205

  13. Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction

    Journal of Cardiovascular Translational Research, Vol. 11, Núm. 4, pp. 310-318

  14. Podiatric adverse events and foot care in cancer patients and survivors: Awareness, education, and literature review

    Journal of the American Podiatric Medical Association, Vol. 108, Núm. 6, pp. 508-516

  15. Position statement for the management of comorbidities in psoriasis

    Journal of the European Academy of Dermatology and Venereology, Vol. 32, Núm. 12, pp. 2058-2073

  16. Prevention of microvascular obstruction by addressing ischemia reperfusion injury-part B: Cardioprotective therapies

    Coronary Microvascular Obstruction in Acute Myocardial Infarction: From Mechanisms to Treatment (Elsevier), pp. 277-293

  17. Septoplastia extracorpórea para la correción nasal en casos complejos. Resultados en 16 pacientes

    Revista Espanola de Cirugia Oral y Maxilofacial, Vol. 40, Núm. 1, pp. 7-14

  18. Switching from endoscopic submucosal dissection to salvage piecemeal knife-assisted snare resection to remove a lesion: a preoperative risk score from the beginning

    Revista Española de Enfermedades Digestivas, Vol. 110, Núm. 11, pp. 699-705

  19. Tecnologías de la Información y la Comunicación (TIC): abuso de Internet, videojuegos, teléfonos móviles, mensajería instantánea y redes sociales mediante el MULTICAGE-TIC

    Adicciones: Revista de socidrogalcohol, Vol. 30, Núm. 1, pp. 19-32

  20. The Brief Sexual Symptom Checklist as a Screening Tool for Sex-Related Problems in the Primary Care Setting: Focus on Erectile Dysfunction

    Urologia Internationalis, Vol. 101, Núm. 1, pp. 98-105